Counterfeit medical products in Ukraine and the world: terminology and definitions, distribution and detection
Why this work is in the frame
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Bibliographic record
Abstract
The purpose of the work was to analyze the terminology and definitions used in the national legislation of developed countries, as well as modern problems of the distribution and detection of drug falsification The object of the study were messages received by the global WHO system – The Global Surveillance and Monitoring System (GSMS), publications on the problems of the distribution of falsified drugs in scientific publications and specialized mass media, regulatory documents of various countries that regulate the circulation of medicinal products. Analysis of scientific and public sources on the falsification of medicines in WHO member countries, as well as data published on the WHO website in the form of warnings, made it possible to establish that falsified medical products are widespread, this problem affects all regions, including highly developed countries, and any – what therapeutic categories of medicines. The most incidents were recorded in Great Britain, China and Nigeria (7 each), the USA and India (6 each), Cameroon (4), Colombia, Ghana, Congo, the Republic of Chad, Israel (3 each), France, Egypt, Turkey, Poland, Bangladesh, Malaysia. Iran, Uzbekistan (2 each), other countries (1 each). Such statistics indicate problems with the regulatory system in the pharmaceutical sector and the effectiveness of counterfeit detection mechanisms. A study of the meaning of the term «counterfeit medicinal product», which is given in the legislation of various countries of the world (Australia, Great Britain, Canada, the USA, China, India), in particular in Ukraine (the current and new version of the Law of Ukraine «On Medicinal Products») and in the EU suggests that this definition is constantly changing, with different countries/organizations offering their own distinctive definitions. With the new version of the Law of Ukraine «On Medicinal Products», the term «falsified medicinal product» was agreed with the definition proposed by the WHO and corresponds to Directive 2001/83/EC. At the same time, it is expedient to implement a new term for drugs that are illegally imported, illegally manufactured, or illegally put into circulation in domestic legislation.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it